Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: Association with chronic rejection

Transplant Immunology

Volumn 5, Issue 1, 1997, Pages 17-24

  Ferry, Berle L ^a   Welsh, Ken I ^a   Dunn, Michael J ^b   Law, David ^a   Proctor, Jeanette ^a   Chapel, Helen ^a   Yacoub, Magdi H ^b   Rose, Marlene L ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOBLOTTING; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD;

EID: 0030902680     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(97)80021-4     Document Type: Article

References (37)

1. Azuma H., Tilney NL. Chronig graft rejection. Curr Opin Immunol. 6:1994;770-776.
2. Hayry P., Yilmaz S. Chronic allograft rejection, an update. Transplant Proc. 26:1994;3159-3160.
3. Banner NR, Fitzgerald M, Khaghani A, et al. Cardiac transplantation at Harefield Hospital. Terasaki P. Clinical transplants. 1987;17-26 Los Angeles, CA, UCLA Tissue Typing Laboratory.
4. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving patients receiving immunosuppressive therapy with cyclosporine and prednisolone. Circulation. 76:1987;827-834.
5. Gratton MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
6. Barbir M, Kushwaha S, Hunt B, et al. Liproprotein (a) and accelerated coronary artery disease in cardiac allograft recipients. Lancet. 340:1992;1500-1502.
7. Bieber CP, Hunt SA, Schwinn DA, et al. Complications in long term survivors of cardiac transplantation. Transplant Proc. 13:1981;207-211.
8. Hosenpud JD, Shipley Gd, Wagner CR. Cardiac allograftvasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant. 11:1992;9-23.
9. Rose ML. Antibody mediated rejection following cardiac transplantation. Transplant Rev. 7:1993;140-152.
10. Petrossian GA, Nichols AB, Marboe CC, et al. Relationship between survival and development of country artery disease and anti-HLA antibodies after cardiac transplantation. Circulation. 80:1989;122-125. (suppl 111).
11. Rose EA, Pepino P, Barr ML, et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac transplant recipients. J Heart Lung Transplant. 11:1992;S120-S123.
12. Hess ML, Hastello A, Mohanokumar T, et al. Accelerated atherosclerosis in cardiac tranplantation. Circulation. 68:1983;94-101. (suppl 11).
13. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet. 339:1992;1566-1570.
14. Crisp SJ, Dunn MJ, Rose ML, Barbir M, Yacoub MH. Antiendothelial antibodies after heart transplantation: the acclerating factor in transplant-associated coronary artery disease? J Heart Lung Transplant. 13:1994;81-92.
15. Hosenpud JD, Everett JP, Morris TE, Mauck FA, Shipley GD, Wagner CR. Cardiac allograft vasculopathy, Association with cell mediated but not humoral alloimmunity to donor specific vascular endothelium. Circulation. 92:1995;205-211.
16. Hardy M, Suciu-Foca F, McKiernan T, et al. The development of specificity of anti-B cell antibodies during humoral rejection of kidney allografts. Transplant Proc. 11:1979;389-392.
17. Mohanakumar T, Waldrep JC, Phibbs M, et al. Serological characterisation of antibodies eluted from chronically rejected human renal allografts. Transplantation. 32:1981;61-66.
18. Brasile L, Rodman E, Shield CF, Clarke J, Cerilli J. The association of antivascular endothelial cell antibody with hyperacute rejection: a case report. Surgery. 99:1986;637-639.
19. Harmer AW, Haskard D, Koffman CG, Welsh KI. Novel antibodies associated with unexplained loss of renal allografts. Transpl Int. 3:1990;66-69.
20. Paul LC, Carpenter CB. Antibodies against renal endothelial alloantigens. Transplant Proc. 12:1980;43-48.
21. Al Hussein KA, Talbot D, Proud G, Taylor RMR, Shenton BK. The clinical significance of post-transplantation non-HLA antibodies in renal transplantation. Transpl Int. 8:1995;214-220.
22. Edgell CJS, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridisation. Proc Natl Acad Sci USA. 80:1983;3734-3737.
23. Ades EW, Candal FJ, Swerlick RA, et al. Establishment of an immortalised human microvascular endothelial cell line. J Invest Dermatol. 99:1992;683-690.
24. Wheeler CH, Collins A, Dunn MJ, Crisp SJ, Yacoub MH, Rose ML. Characterisation of endothelial antigens associated with transplant associated coronary artery disease. J Heart Lung Transplant. 14:1995;S188-S197.
25. Martin S, Dyer PA, Mallick NP, Gokal R, Harris R, Johnson RWG. Post-transplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation. 44:1987;50-53.
26. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti class I response II. Clinical and pathological featutres of renal transplants with anti class I antibody. Transplantation. 53:1992;550-555.
27. Suciu-Foca N, Reed E, Marboe C, et al. The role of anti-HLA antibodies in heart transplantation. Transplantation. 51:1991;716-724.
28. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Specificity of lymphocytotxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation. 53:1992;1358-1362.
29. Brasile L, Zerbe T, Rabin B, Clarke J, Abrams A, Cerilli J. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Transplantation. 40:1985;672-675.
30. Trento A, Hardesty RL, Griffith BP, Zerbe T, Kormos RL, Bahnson HT. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. J Thorac Cardivoasc Surg. 95:1988;37-41.
31. Tixier D, Tuso P, Czer L, et al. Characterisation of antiendothelial cell and antiheart antibodies following heart transplantation. Transplant proc. 25:1993;931-934.
32. Yard B, Spruyt-Gerritse M, Claas F, et al. The clinical significance of allospecific antibodies against endothelial cells detected with an antibody dependent cellular cytoxicity assay for vascular rejection and graft loss after renal transplantation. Transplantation. 55:1993;1287-1293.
33. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley CD. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:1987;506-512.
34. Khamashta MA, Highes GRV, Pearson JD. Antibodies to endothelial cells and vascular dysfunction in progressive systemic sclerosis and mixed connective tissue disease. Cervera C. Endothelial cells and vascular damage. 1994;111-119 CRC Press Inc. Boca Raton, FL.
35. Page CS, Rose ML, Yacoub MH, Pigott R. Antigenic heterogeneity of vascular endothelium. Am. J Pathol. 141:1992;673-683.
36. Abdul-Karim AB, Barnes AD, Bevan IS, et al. Anti-epithelial (anti-549)_antibodies: their nature, specificity and relevance to transplantation. Transplant Immunol. 3:1995;192-202.
37. Pidwell DJ, Heller MJ, Gabler D, Orosz C. In vitro stimulation of human endothelial cells by sera from a subpopulation of high percentage panel reactive antibody patients. Transplantation. 60:1995;56-569.